ESLOY
Price
$145.20
Change
+$1.05 (+0.73%)
Updated
May 2 closing price
Capitalization
90.98B
86 days until earnings call
QGEN
Price
$43.13
Change
+$0.93 (+2.20%)
Updated
May 2 closing price
Capitalization
9.52B
4 days until earnings call
Ad is loading...

ESLOY vs QGEN

Header iconESLOY vs QGEN Comparison
Open Charts ESLOY vs QGENBanner chart's image
EssilorLuxottica
Price$145.20
Change+$1.05 (+0.73%)
Volume$29.23K
Capitalization90.98B
Qiagen
Price$43.13
Change+$0.93 (+2.20%)
Volume$1.2M
Capitalization9.52B
ESLOY vs QGEN Comparison Chart
Loading...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLOY vs. QGEN commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOY is a Buy and QGEN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (ESLOY: $145.20 vs. QGEN: $43.13)
Brand notoriety: ESLOY and QGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ESLOY: 83% vs. QGEN: 98%
Market capitalization -- ESLOY: $90.98B vs. QGEN: $9.52B
ESLOY [@Medical Specialties] is valued at $90.98B. QGEN’s [@Medical Specialties] market capitalization is $9.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOY’s FA Score shows that 3 FA rating(s) are green whileQGEN’s FA Score has 1 green FA rating(s).

  • ESLOY’s FA Score: 3 green, 2 red.
  • QGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, ESLOY is a better buy in the long-term than QGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOY’s TA Score shows that 6 TA indicator(s) are bullish while QGEN’s TA Score has 5 bullish TA indicator(s).

  • ESLOY’s TA Score: 6 bullish, 4 bearish.
  • QGEN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ESLOY is a better buy in the short-term than QGEN.

Price Growth

ESLOY (@Medical Specialties) experienced а +0.27% price change this week, while QGEN (@Medical Specialties) price change was +2.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.26%. For the same industry, the average monthly price growth was -1.11%, and the average quarterly price growth was -1.23%.

Reported Earning Dates

ESLOY is expected to report earnings on Jul 28, 2025.

QGEN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($91B) has a higher market cap than QGEN($9.52B). ESLOY has higher P/E ratio than QGEN: ESLOY (34.13) vs QGEN (27.85). ESLOY YTD gains are higher at: 20.328 vs. QGEN (-0.182). ESLOY has higher annual earnings (EBITDA): 6.23B vs. QGEN (689M). ESLOY has more cash in the bank: 1.69B vs. QGEN (1.06B). QGEN has less debt than ESLOY: QGEN (1.53B) vs ESLOY (11.7B). ESLOY has higher revenues than QGEN: ESLOY (25.4B) vs QGEN (1.97B).
ESLOYQGENESLOY / QGEN
Capitalization91B9.52B956%
EBITDA6.23B689M904%
Gain YTD20.328-0.182-11,148%
P/E Ratio34.1327.85123%
Revenue25.4B1.97B1,293%
Total Cash1.69B1.06B160%
Total Debt11.7B1.53B764%
FUNDAMENTALS RATINGS
ESLOY vs QGEN: Fundamental Ratings
ESLOY
QGEN
OUTLOOK RATING
1..100
1921
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
1275
SMR RATING
1..100
9687
PRICE GROWTH RATING
1..100
4350
P/E GROWTH RATING
1..100
243
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOY's Valuation (16) in the null industry is significantly better than the same rating for QGEN (85) in the Medical Specialties industry. This means that ESLOY’s stock grew significantly faster than QGEN’s over the last 12 months.

ESLOY's Profit vs Risk Rating (12) in the null industry is somewhat better than the same rating for QGEN (75) in the Medical Specialties industry. This means that ESLOY’s stock grew somewhat faster than QGEN’s over the last 12 months.

QGEN's SMR Rating (87) in the Medical Specialties industry is in the same range as ESLOY (96) in the null industry. This means that QGEN’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's Price Growth Rating (43) in the null industry is in the same range as QGEN (50) in the Medical Specialties industry. This means that ESLOY’s stock grew similarly to QGEN’s over the last 12 months.

QGEN's P/E Growth Rating (3) in the Medical Specialties industry is in the same range as ESLOY (24) in the null industry. This means that QGEN’s stock grew similarly to ESLOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESLOYQGEN
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
62%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
49%
MACD
ODDS (%)
Bullish Trend 1 day ago
60%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
56%
Declines
ODDS (%)
Bearish Trend 13 days ago
50%
Bearish Trend 13 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
57%
Aroon
ODDS (%)
Bearish Trend 1 day ago
36%
Bullish Trend 1 day ago
45%
View a ticker or compare two or three
Ad is loading...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAMEX19.720.45
+2.34%
MoA Mid Cap Equity Index Fund
MVIAX17.21N/A
N/A
Praxis Value Index A
VYSVX18.21N/A
N/A
Vericimetry US Small Cap Value
BGSAX60.30N/A
N/A
BlackRock Technology Opportunities Inv A
LHCCX17.29N/A
N/A
Lord Abbett Health Care C

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+0.73%
ESLOF - ESLOY
58%
Loosely correlated
+2.41%
QGEN - ESLOY
43%
Loosely correlated
+2.20%
ALC - ESLOY
38%
Loosely correlated
+2.21%
SMMNY - ESLOY
38%
Loosely correlated
+1.31%
CRL - ESLOY
35%
Loosely correlated
+1.34%
More

QGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with TMO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
+2.20%
TMO - QGEN
60%
Loosely correlated
+0.87%
A - QGEN
58%
Loosely correlated
+2.04%
RVTY - QGEN
57%
Loosely correlated
+1.17%
DHR - QGEN
56%
Loosely correlated
+1.19%
WAT - QGEN
53%
Loosely correlated
+2.52%
More